These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2806492)

  • 1. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease.
    Vestbo J; Rasmussen FV
    Eur Respir J; 1989 Sep; 2(8):710-5. PubMed ID: 2806492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.
    Prescott E; Bjerg AM; Andersen PK; Lange P; Vestbo J
    Eur Respir J; 1997 Apr; 10(4):822-7. PubMed ID: 9150319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
    Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
    Am Rev Respir Dis; 1990 Mar; 141(3):613-7. PubMed ID: 2310094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway obstruction in relation to symptoms in chronic respiratory disease--a nationally representative population study.
    von Hertzen L; Reunanen A; Impivaara O; Mälkiä E; Aromaa A
    Respir Med; 2000 Apr; 94(4):356-63. PubMed ID: 10845434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.
    Vestbo J; Knudsen KM; Rasmussen FV
    Respir Med; 1989 May; 83(3):207-11. PubMed ID: 2595038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal methods for describing the relationship between pulmonary function, respiratory symptoms and smoking in elderly subjects: the Tucson Study.
    Sherrill DL; Lebowitz MD; Knudson RJ; Burrows B
    Eur Respir J; 1993 Mar; 6(3):342-8. PubMed ID: 8472823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of smoking and occupation on changes in respiratory symptoms in middle-aged Danish men.
    Vestbo J; Knudsen KM; Rasmussen FV
    Eur Respir J; 1990 Sep; 3(8):880-5. PubMed ID: 2292284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host factors in chronic obstructive pulmonary disease in an upper Midwest rural community. Design, case selection, and clinical characteristics in a matched-pair study.
    Miller RD; Hepper NG; Kueppers F; Gordon H; Offord KP
    Mayo Clin Proc; 1976 Nov; 51(11):709-15. PubMed ID: 1086934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometry utilisation among Danish adults initiating medication targeting obstructive lung disease.
    Koefoed MM
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand.
    Fishwick D; Bradshaw LM; D'Souza W; Town I; Armstrong R; Pearce N; Crane J
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1440-6. PubMed ID: 9372658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.
    Chambers DC; Boldy DA; Ayres JG
    Respir Med; 1999 Oct; 93(10):726-33. PubMed ID: 10581662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III.
    Scannapieco FA; Ho AW
    J Periodontol; 2001 Jan; 72(1):50-6. PubMed ID: 11210073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of respiratory failure after high-risk surgery on the thoracoabdominal aorta.
    Svensson LG; Hess KR; Coselli JS; Safi HJ; Crawford ES
    J Vasc Surg; 1991 Sep; 14(3):271-82. PubMed ID: 1880835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What predicts change in pulmonary function and quality of life in asthma or COPD?
    Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
    J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of COPD symptoms: does the sex of the patient matter?
    Watson L; Schouten JP; Löfdahl CG; Pride NB; Laitinen LA; Postma DS;
    Eur Respir J; 2006 Aug; 28(2):311-8. PubMed ID: 16707516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.